Recombinant Oncolytic Poliovirus, PVSRIPO, Has Potent Cytotoxic and Innate Inflammatory Effects, Mediating Therapy in Human Breast and Prostate Cancer Xenograft Models

Oncotarget - United States
doi 10.18632/oncotarget.12975
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

A Potent Oncolytic Herpes Simplex Virus for the Therapy of Advanced Prostate Cancer

2004English

Inflammatory Breast Cancer: Vasculogenic Mimicry and Its Hemodynamics of an Inflammatory Breast Cancer Xenograft Model

Breast Cancer Research
Cancer ResearchOncology
2003English

Systemic Oncolytic Cytokine HSV Therapy of Prostate Cancer

2007English

Pharmacokinetic/Pharmacodynamic Modeling of Schedule-Dependent Interaction Between Docetaxel and Cabozantinib in Human Prostate Cancer Xenograft Models

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2017English

Patient-Derived Xenograft (PDX) Models in Basic and Translational Breast Cancer Research

Cancer and Metastasis Reviews
Cancer ResearchOncology
2016English

Anti-Cancer Effects of Oncolytic Viral Therapy Combined With Photodynamic Therapy in Human Pancreatic Cancer Cell Lines

The Lancet
Medicine
2015English

Potent 19-Norvitamin D Analogs for Prostate and Liver Cancer Therapy

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2012English

RGD-modifided Oncolytic Adenovirus Exhibited Potent Cytotoxic Effect on CAR-negative Bladder Cancer-Initiating Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2015English

Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy